Brighton Jones’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$190K Sell
17,773
-5,174
-23% -$57.9K ﹤0.01% 1279
2026
Q2
$252K Buy
22,947
+9,292
+68% +$87.7K ﹤0.01% 1142
2026
Q1
$111K Buy
+13,655
New +$117K ﹤0.01% 1121
2025
Q4
– Sell
-12,196
Closed -$108K – 545
2025
Q3
$108K Buy
+12,196
New +$86.9K ﹤0.01% 989

Other funds holding KURA

Brighton Jones's KURA Position: Q3 2026 in Review

Brighton Jones reduced its Kura Oncology (KURA) stake by 23% in Q3 2026, selling an estimated $57.9K and leaving 17,773 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

Brighton Jones first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. The position peaked at $252K in Q2 2026. 192 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Brighton Jones held 17,773 shares of Kura Oncology worth $190K as of Q3 2026.
  • Brighton Jones sold 5,174 Kura Oncology shares in Q3 2026, an estimated $57.9K.
  • Kura Oncology made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1279 holding.
  • Brighton Jones first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
  • Brighton Jones's Kura Oncology position peaked at $252K in Q2 2026.
  • 192 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.